Minister stresses importance of strong pharmaceutical manufacturing industries for economic stability

Health and Industries Minister Dr. Ramesh Pathirana yesterday underscored the critical role of steadfast pharmaceutical manufacturing industries in ensuring economic stability and to ensure a healthy nation. 

In a meeting with local pharmaceutical manufacturers held at the Health Ministry, he emphasised that historical data strongly supports this assertion.

The objective of the discussion was to strengthen the understanding between the Health Ministry and pharmaceutical manufacturers, with a shared vision of boosting domestic production to ensure the availability of critical medicines for the people. 

Dr. Pathirana asserted that the production of essential medicines within the country is imperative, and assured that both the Government and the Health Ministry will extend the necessary support for this endeavour. 

He also stressed the importance of transparency in this process, insisting on a methodical approach towards formalising the initiative.

Commenting on the pharmaceutical industry in Sri Lanka, Dr. Pathirana acknowledged that there is room for improvement. 

He noted that the public has a negative perception of the Health Ministry and its leadership it was everyone’s responsibility to work towards improving and clarifying this negative opinion.

The Minister also highlighted the potential for significant cost savings by boosting domestic pharmaceutical production, pointing out the substantial revenues earned by o countries like India, Pakistan and Bangladesh through their pharmaceutical sectors.

Dr. Pathirana instructed officials to ensure that payments to pharmaceutical manufacturers adhere to proper protocols. He stressed the importance of timely delivery to prevent drug shortages and advised manufacturers to promptly register new drugs with the National Drug Regulatory Authority, providing the requisite documentation.

Currently, only 15%-20% of Sri Lanka’s pharmaceutical requirements are produced domestically, with the majority imported. It incurs an annual expenditure of over $ 700 million for the Government. Sri Lanka imports 1,347 types of medicines annually, of which 862 are prioritised for patient treatment, with only 208 being locally produced.

The meeting saw the participation of key figures including State Minister of Health Dr. Sita Arambepola, Health Ministry Secretary Janaka Chandragupta, Health Services Director-General Dr. Asela Gunawardena, National Medicines Regulatory Authority Chairman Dr. Ananda Wijewickrama, State Pharmaceutical Corporation Chairman Dr. Ajith Mendis, Medical Supply Division Director Dr. Kapila Wickramanayake, as well as representatives from the local pharmaceutical industry.